Case Comprehensive Cancer Center: Neoplasms trials

The registry lists 36 Neoplasms studies with Case Comprehensive Cancer Center as lead sponsor. 6 are open to participants now and 4 have results posted.

Early Phase 1 1Phase 1 9Phase 2 4Phase 3 1No phase 22(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical TrialsRecruitingNCT07541365Not applicable
• Artificial Intelligence-Powered Support For Quality Of Life Improvement In Participants With CancerRecruitingNCT07167056Not applicable
• Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)Not yet recruitingNCT06811454Not applicable
• Promoting Access, Resources and Treatment Through Novel and Equitable Solutions for Cancer CareRecruitingNCT06481774Not applicable
• Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral BreastRecruitingNCT06129747Phase 2
• Proton Therapy Patient RegistryRecruitingNCT02986048
• Comparison of Yttrium-90 Absorbed Doses Using PET/CT Versus PET/MR Imaging for Hepatic MalignanciesCompletedNCT04332419Not applicableResults posted
• Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Cancer PatientsCompletedNCT04055948Not applicableResults posted
• Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II StudyTerminatedNCT02345460Phase 2Results posted
• Positron Emission Tomography/Magnetic Resonance Imaging in PatientsTerminatedNCT01557881Not applicableResults posted
• Study of Disulfiram to Reduce Myeloid Immunosuppression and Steroid Dependence in Resectable High Grade GliomaSuspendedNCT07719127Phase 1
• Decreasing Chemotherapy Induced Distress Using Immersive Virtual Reality in Patients With CancerCompletedNCT06446115Not applicable
• Individualized Treatments in Adults With Relapsed/Refractory CancersCompletedNCT06024603Not applicable
• Multidimensional Prehabilitation in Pancreatic Surgery for Pancreatic and Periampullary NeoplasmsCompletedNCT05225038Not applicable
• A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary DoseCompletedNCT05142358Not applicable
• Fluciclovine (Axumin) PET/CT vs. NaF PET/CT in Prostate Cancer Osseous Metastatic DiseaseWithdrawnNCT04765423Not applicable
• Single-Port Versus Multi-Port Robotic Radical ProstatectomyWithdrawnNCT04696263Not applicable
• Captopril Use on the Degree of Marrow Fibrosis in Bone Marrow Fibrosis/Myeloproliferative NeoplasmsWithdrawnNCT04629651Phase 1/2
• 18F-Fluciclovine PET to Distinguish Tumor Progression From Radiation NecrosisCompletedNCT03930173Early Phase 1
• Debulking Surgery in Ovarian CancerCompletedNCT03378128Not applicable
• Breast Reconstruction Following Breast Cancer in Very High Risk PatientsWithdrawnNCT03261323Not applicable
• Early Oral Supplementation in Improving Nutritional Status in Patients Undergoing Hematopoietic Stem Cell TransplantTerminatedNCT02590107Not applicable
• Dual Energy Computed Tomography (CT) in Finding Bone Metastases in Patients With CancerTerminatedNCT02354326
• Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02129582Phase 1
• NaF PET/MRI Evaluation for Bone Metastases in Breast CancerCompletedNCT02103634
• Tailoring Patient Education to Perceived Risk for Falls in Hospitalized Oncology PatientsCompletedNCT02081794Not applicable
• Screening and Risk Factors of Colon NeoplasiaCompletedNCT01647776
• Methoxyamine and Temozolomide in Treating Patients With Advanced Solid TumorsCompletedNCT00892385Phase 1
• Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical TrialCompletedNCT00750009Phase 3
• CC-4047 in Treating Patients With Advanced Solid Tumors That Did Not Respond to TreatmentCompletedNCT00482521Phase 1
• Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for CancerWithdrawnNCT00402935
• Lenalidomide and Docetaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00253344Phase 1
• Campath-1H + FK506 and Methylprednisolone for GVHDCompletedNCT00109993Phase 2
• GW786034 in Treating Patients With Advanced Solid TumorsCompletedNCT00060151Phase 1
• Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00006465Phase 1
• Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaTerminatedNCT00003567Phase 1